The CCK8 assay demonstrated that compared to free GEM, the proliferation-inhibiting effect of GEM-HSA-NP on MDR1- and MRP1-overexpressing pancreatic cancer cells remained potent. This evidence concerns the gene ABCB1 and familial pancreatic carcinoma.